Uncategorized Archives - Page 72 of 145

WednesdayOct 06, 2021 9:30 am

Sleep Apnea More Prevalent Among Children, Can Impact Grades

Nemours Children’s Health director of preventive cardiology Dr. Carissa Baker-Smith stated in a recent interview that disrupted and poor sleep in children could be linked to difficulty focusing in the daytime. This, she added, could negatively affect their performance in school. Sleep apnea is a sleeping disorder known to cause serious health problems. When untreated, sleep apnea causes an individual’s breathing to stop repeatedly while they’re sleeping. This, in turn, causes loud snoring and fatigue in the daytime, despite having a full night’s sleep. The main types of sleep apnea are: Central sleep apnea This occurs when an individual’s brain…

WednesdayOct 06, 2021 9:00 am

Nemaura Medical Inc. (NASDAQ: NMRD) Harnesses the Power of Patient-Provider Communication

NMRD has developed a proprietary technology that replaces traditional invasive methods of diagnosis and healthcare observation procedures Report notes that study participants are interested in using electronic methods to communicate more with their doctors between visits Better communication between patients and their healthcare providers impacts adherence to prescribed treatment According to a report published in Dove Medical Press, communication between patients and their physicians has a notable impact on adherence to prescribed treatment and improved health care (https://ibn.fm/ZMYMQ). As a company focused on providing digital and glucose monitoring solutions for patients dealing with diabetes, Nemaura Medical (NASDAQ: NMRD) pays special…

TuesdayOct 05, 2021 1:01 pm

RYAH Group Inc. (CSE: RYAH) Reveals Attendance at the Wall Street Reporter’s Next Super Stock Livestream Conference

RYAH Group is a digital healthcare analytics and technology company focused on developing tools that provide patients and doctors with the ability to accurately manage the intake in plant-based treatment The company recently revealed its participation at the Wall Street Reporter’s ‘Next Super Stock’ livestream conference held on September 23, 2021 RYAH Group (CSE: RYAH) is a leading digital health care analytics and technology company with a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. The company specializes in developing volume-control IoT devices to provide accurate volume control and management for various medical…

TuesdayOct 05, 2021 12:43 pm

What You Should Know About Traumatic Brain Injuries and PTSD

Brain injuries usually occur when an individual is involved in some trauma such as a fall, a blast or an accident while traumatic brain injuries occur from a sudden jolt or blow to the head. Traumatic brain injuries can be severe, moderate or mild, and are similar to concussions. Oftentimes, when individuals refer to traumatic brain injuries, they talk about the symptoms that occur following the injury, forgetting the fact that a traumatic brain injury is an actual injury. Nearly 80% of all traumatic brain injuries in people are considered mild, with a majority of these patients fully recovering in…

MondayOct 04, 2021 1:15 pm

Researchers Find Colorectal Cancer Cases Are Higher in Minorities

Marvella Ford and Kristin Wallace are among researchers who have studied colorectal cancer disparities and rates. These researchers are becoming increasingly concerned as more young individuals are diagnosed with this cancer. Wallace recently published a study that looked at genetic markers which could explain the disparities in outcomes and diagnoses between whites and African Americans earlier in the year. The study, which was published in “Frontiers in Oncology,” found that in comparison with whites, African Americans had a lower prevalence of rectal noncancerous tumors and were generally more susceptible to noncancerous tumors. The study also found that these lesions had…

FridayOct 01, 2021 3:28 pm

How Technological Innovation May Transform Alzheimer’s Diagnosis

Each year, we celebrate World Alzheimer’s Day on September 21, hoping that every passing day brings us one step closer to a cure. Alzheimer’s disease is a progressive ailment that destroys an individual’s memory and other important mental functions. Researchers believe that the disease may be caused by an abnormal buildup of proteins around and in brain cells. In its late stage, the disease causes individuals to lose their ability to carry on conversations and respond to their environments. With new cases of the disease developing every three seconds, it becomes even more important to diagnose and treat this disease…

FridayOct 01, 2021 9:00 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Launches The Desire Project to Promote MDMA-Assisted Psychotherapy Treatment for HSDD

Although an often unspoken of medical disorder, Hypoactive Sexual Desire Disorder affects approximately 9.5 million women in the U.S. alone The project gathers some of the world’s leading researchers in female sexual desire and psychedelics This is the first-of-its-kind psychedelic-based treatment program targeting this disorder, with potential global implications Clinical trials of MDMA as a treatment for PTSD have shown some success due to targeting the pathways that process fear MINDCURE is working with a molecule that will be first-to-market - MDMA is predicted to be approved by 2023 – this brings them closer to the money Mind Cure Health…

ThursdaySep 30, 2021 1:24 pm

Seven Symptoms of Brain Cancer You Shouldn’t Ignore

An individual’s lifetime risk of developing a spinal cord or malignant brain tumor is under 1%. The American Cancer Society reveals that even when primary brain tumors do occur, more than half of them are benign, which means that they are not cancerous. Dr. Alyx B. Porter, a neuro-oncologist who is also the medical director of the Mayo Clinic Outpatient Practice in Arizona, states that the main known risk factors for brain tumors are a family history with genetic predisposition to some cancers or tumors and being exposed to radiation. Below are the most common symptoms of a brain tumor,…

ThursdaySep 30, 2021 11:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Achieves Most Important Milestone Yet with Submission of IND Application for Phase 2a Clinical Trial

Tryp Therapeutics on September 22 submitted an IND application to the FDA to evaluate its oral formulation of synthetic psilocybin, TRP-8802, in a Phase 2a clinical study The study seeks to evaluate TRP-8802 for the treatment of patients with eating disorders and will enroll 10 patients According to Tryp Chairman and CEO, the submission is the first of several IND filings the company intends to make in the coming months Tryp is also preparing for Phase 2b clinical trials, which will evaluate its proprietary drug candidate, TRP-8803 During a recent investor presentation, Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical…

WednesdaySep 29, 2021 10:53 am

Treatment Modalities for Soft Tissue Sarcomas in the Extremities Differ by Age Group

A new study has found that young individuals suffering from extremity soft tissue sarcoma are less likely to receive radiation and more likely to undergo chemotherapy when compared with older individuals. The study was reported in “JAMA Network Open.” Extremity soft tissues sarcomas are a rare group of tumors that commonly occur in an individual’s extremities. For their research, the scientists carried out a retrospective study that included more than 8,900 patients and compared the utilization of definitive treatment from 2004 to 2014. The cohorts from the National Cancer Database comprised of about 3,750 patients aged 65 and above, roughly…